|
|
| Line 1: |
Line 1: |
| − | | + | \ |
| − | Protocol: Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)
| + | |
| − | Strains: Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs
| + | |
| − | Source: DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA)
| + | |
| − | Papers:
| + | |
| − | • Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534.
| + | |
| − | • Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.
| + | |
| − | | + | |
| − | Materials
| + | |
| − | • DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)
| + | |
| − | • FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)
| + | |
| − | • NCS (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)
| + | |
| − | • Penicillin/Streptomycin (100X Invitrogen Cat# 100378-016)
| + | |
| − | • Insulin (Sigma I-5523). Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock. Aliquot into 1.5 mL tubes and store at -20
| + | |
| − | • Dexamethasone (Sigma D-1756). Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml). Aliquot into 1.5 tubes and store at -20.
| + | |
| − | • MIX (Sigma I-5879). Add 2.78g MIX and 0.98g KOH and bring up to 50 mL. Aliquot into 1.5 mL tubes and store at -20
| + | |
| − | • Fibroblast Media (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)
| + | |
| − | • Adipocyte Media (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)
| + | |
| − | • DMI Media (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions
| + | |
| − | • Insulin Media (Adipocyte Media + Insulin; Sterile filter into new bottle after adding insulin)
| + | |
| − | | + | |
| − | | + | |
| − | Induction of MEF differentiation:
| + | |
| − | 1. Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).
| + | |
| − | 2. On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).
| + | |
| − | 3. At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off).
| + | |
| − | • Note1 Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)
| + | |
| − | 4. Protein lysate and RNA extraction is taken at day 4 (D3).
| + | |
| − | • Note2: In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection.
| + | |
| − | • Note3: A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.
| + | |
